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ABSTRACT: Many natural organic compounds with pharma-
ceutical applications, including antibiotics (chlortetracycline
and vancomycin), antifungal compounds (pyrrolnitrin), and
chemotherapeutics (salinosporamide A and rebeccamycin) are
chlorinated. Halogenating enzymes like tryptophan 7-halogen-
ase (PrnA) and tryptophan 5-halogenase (PyrH) perform
regioselective halogenation of tryptophan. In this study, the
conformational dynamics of two ﬂavin-dependent tryptophan
halogenasesPrnA and PyrHwas investigated through
molecular dynamics simulations, which are in agreement with
the crystallographic and kinetic experimental studies of both
enzymes and provide further explanation of the experimental
data at an atomistic level of accuracy. They show that the
binding sites of the cofactor-ﬂavin adenine dinucleotide and the
substrate do not come into close proximity during the simulations, thus supporting an enzymatic mechanism without a direct
contact between them. Two catalytically important active site residues, glutamate (E346/E354) and lysine (K79/K75) in PrnA
and PyrH, respectively, were found to play a key role in positioning the proposed chlorinating agent, hypochlorous acid. The
changes in the regioselectivity between PrnA and PyrH arise as a consequence of diﬀerences in the orientation of substrate in its
binding site.
■ INTRODUCTION
Many pharmaceutically important natural organic compounds
(including antibiotics, such as chlortetracycline1 and vancomy-
cin,2 the antifungal compound pyrrolnitrin3 and chemo-
therapeutics, such as salinosporamide A4 and rebeccamycin5)
are chlorinated. Halogenating enzymes perform regioselective
halogenation of aromatic compounds eﬃciently in a solution
using only chloride ions at physiological temperatures and
atmospheric pressure. However, selective nonenzymatic chlori-
nation of the C−H bonds is a chemical synthesis challenge.6
For example, the halogenation of tryptophan in the solution
lacks regioselectivity and produces a mixture of products with
chlorine added at the 1st, 5th, and 7th carbon of the indole
ring.7 From an industrial point of view, this is unacceptable, as
the desired isomer is produced with a lower yield and is
expensive to separate from the other isomers. Interestingly,
many natural products with pharmaceutical relevance contain
halogen atoms at a range of diﬀerent positions. These would be
diﬃcult to synthesize chemocatalytically and rely on the use of
protecting groups and metal-based catalysts. Such strategies
introduce extra reaction steps to the synthesis, increasing
ﬁnancial costs and lowering yields.8 Hence, a detailed
understanding of the enzymatic mechanism of regioselective
chlorination/halogenation of natural organic compounds and
knowledge of the origin of the regioselectivity is of importance
to organic chemical synthesis. Halogenating enzymes are
attractive as biocatalysts because they can be engineered to
suit diﬀerent synthetic purposes,9 not only adjusting their
regioselectivity but also their ability to accept a range of
diﬀerent substrates, such as indoles and other aryl-based
substrates.10
The indole ring of tryptophan gets chlorinated at diﬀerent
positions of the 5th, 6th, or 7th carbon atom by distinct ﬂavin-
dependent halogenases, these include tryptophan 5-halogenase
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(PyrH11), tryptophan 6-halogenases (Thal12 and SttH13), and
tryptophan 7-halogenases (RebH14 and PrnA15), respectively.
All of these enzymes exhibit high levels of regio- and
stereoselectivity. For example, chlorination of the indole ring
of tryptophan at its sixth carbon atom by tryptophan 6-
halogenase (Thal12) has been suggested to be the ﬁrst step of
the biosynthesis of the indole alkaloid thienodolina natural
compound that exhibits plant growth-regulating activity. Our
study focuses on the structural analysis through extensive
molecular dynamics (MD) simulations of two ﬂavin-dependent
halogenases, namely, PrnA (tryptophan 7-halogenase) and
PyrH (tryptophan 5-halogenase). PrnA catalyzes the chlorina-
tion of free tryptophan to 7-chlorotryptophan as a ﬁrst step in
the biosynthesis of the antibiotic and antifungal compound
pyrrolnitrin.3 PyrH catalyzes the chlorination of free tryptophan
to 5-chlorotryptophan as a part of the biosynthesis of the
antibiotic pyrroindomycin B.11 It is important to understand
the reasons for regioselectivity, with a focus on the structural
diﬀerences at the active sites of these structurally similar
enzymes.
X-ray crystallographic structures of the two halogenases are
available from the Protein Data Bank (PDB).15,16 The structure
of PrnA is shown in Figure 1.
Several reaction mechanisms were proposed for the
enzymatic chlorination of tryptophan performed by tryptophan
7-halogenase.9 In the van Peé mechanism, the aryl ring of
tryptophan reacts directly with hydroperoxy-FAD to produce a
hydroxylated tryptophan intermediate.17 The positively charged
intermediate is then attacked by a chloride ion to produce a
chlorinated hydroxyl-tryptophan product. This product under-
goes an elimination of water to produce the chlorinated
tryptophan product.17 In the Walsh mechanism, chloride
attacks hydroperoxy-FAD to produce a FAD-OCl intermediate.
The tryptophan substrate (Trp-S) can then attack the chlorine
of the FAD-OCl intermediate in a classical electrophilic
aromatic substitution reaction.18 The van Peé and Walsh
mechanisms rely on the possibility that the FAD and
tryptophan-binding sites of the enzyme can be brought within
a suitable proximity for direct contact between the FAD and
Trp-S.17,18 Inspection of the crystal structures of the known
FAD-dependent halogenase enzymes shows a >10 Å distance
between the FAD and tryptophan-binding sites (Figure 2).11−15
The separation between the ligands would be too distant for
direct interaction. However, close contact between the cofactor
and the substrate, though not observable in the crystal
structure, is a possibility that cannot be entirely excluded. A
large conformational change could take place in the protein
structure, bringing the two binding sites into close proximity
and allowing direct reaction between the two ligands.
A third mechanism put forward by Naismith et al. suggests
that hypochlorous acid is produced at the FAD-binding site by
the reaction of a chloride ion and hydroperoxy-FAD.
Hypochlorous acid then travels through a channel between
the FAD and tryptophan-binding sites.15,19 Once in proximity
to tryptophan, the active site lysine and glutamate residues
facilitate a reaction between hypochlorous acid and tryptophan
to produce the chlorinated tryptophan product.15,20 Because
the FAD- and tryptophan-binding sites are distant, the
chlorinating agent, hypochlorous acid, is thought to travel
through a channel in the protein.15 Two amino acids K79 and
E346 in PrnA (analogous to K75 and E354 in PyrH) are
positioned in close proximity to the reactive carbon of
Figure 1. X-ray PrnA structure drawn using PrnA displayed in
silhouette round ribbon. Substrate (Trp-S), cofactor FAD, chlorination
agent, hypochlorous acid, and the side chains of the catalytically
important K79 and E346 are shown in tube representation.
Hypochlorous acid and the to-be halogenated carbon of Trp-S are
shown in spherical representation. Carbons are green, nitrogens are
dark blue, oxygens are red, and hydrogens are white.
Figure 2. Two diﬀerent views A and B of the ribbon representation of
the PrnA crystal structure, with Trp-S, FAD, hypochlorous acid, K79,
and E346 rendered as tubes and labeled. Hypochlorous acid and the
to-be halogenated carbon of Trp-S are represented with a sphere
rendering. Carbons are bright green and additional element colors are
as follows: nitrogen is dark blue, oxygen is red, and hydrogen is white.
In addition, the distance between the FAD C4A carbon and Trp-S C7
atom is drawn with a dashed line and the distance is labeled in blue.
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tryptophan’s indole ring. They are thought to be involved in the
activation of the hypochlorous acid for the halogenation step of
the reaction.19 The role of K79 and E346 in PrnA is supported
by an experimental mutagenesis, showing that the K79A
mutant had no detectable activity, and in the E346Q mutant,
the Kcat value for the halogenation is decreased by 2 orders of
magnitude.15
PyrH and PrnA share a 40% sequence identity and a 58%
sequence similarity, making their structures similar.21 Despite
this similarity, the catalytic turnovers of tryptophan 7-
halogenase and tryptophan 5-halogenase diﬀer. For example,
PyrH was found to convert 100% of its Trp-S, whereas PrnA
converted only 59% of its substrate and the origin of this
diﬀerence has not yet been elucidated.10 In the FAD-binding
site of the crystal structure of PyrH, a “strap” region was
identiﬁed and hypothesized as a structural feature that allows
for “communication” between the two binding sites that are
involved in the regulation of FAD binding. The overlaid crystal
structures of PyrH and PrnA reveal that the FAD-binding sites
are almost identical (Figure 3). Structural analysis showed that
PyrH possesses a structurally diﬀerent tryptophan binding site
to that of PrnA. Trp-S in the PyrH crystal structure is bound in
a way that is upside down with respect to tryptophan in the
PrnA crystal structure (Figure 3). However, the to-be
halogenated carbon of Trp-S in PrnA (C7) and PyrH (C5)
superimpose well when the two protein structures are aligned.
The positioning of the reactive carbon is located between the
active site lysine and glutamate residues, which show similar
orientation across the two enzymes. In a recent study
investigating the reaction mechanism for the chlorination of
tryptophan in PrnA, quantum mechanics (QM)/molecular
mechanics (MM) methods were applied to study the potential
energy and free energy surfaces of the chlorination reaction.22
Key atomistic interactions in the stationary points and energetic
changes along the reaction path were explored. They reported
that E346 fulﬁlls the role of a proton acceptor and hydrogen-
bonding residue for Trp-S, whereas K79 acts as a proton donor
and hydrogen-bonding residue for the hypochlorous acid. The
structural data suggest that the reason for diﬀerent
regioselectivity of the two enzymes would be related to the
binding interactions of Trp-S in the active sites.22
Enzymes are large, ﬂexible, and dynamic molecules that
naturally undergo a wide range of conformational changes and
molecular motions ranging from femtoseconds to hours.23
Many of these motions are functionally important and relate
enzyme structure to function.24 Experimentally determined
protein structures (e.g., by X-ray crystallography) provide
valuable structural information, however, limited to a static
structure, averaged over the number of molecules in the crystal
lattice, and the duration of the experiment.25 In addition, steric
eﬀects can also arise due to the compactness of the crystal
environment.26 Enzyme conformational ﬂexibility plays a
substantial role in stabilizing the protein interactions vital in
facilitating ligand binding and unbinding events.27 Molecular
plasticity is involved in assisting the migration of ligands to the
binding site, as well as the diﬀusion of gases and small
molecules through the protein.28 Mutations of key residues,
involved in catalysis and binding, can not only inﬂuence locally
the structure but also exercise a long-range structural eﬀect on
the protein conformation as a whole. Exploration of the
dynamic events in proteins, using experimental methods, can be
a challenge; thus, computer-based experiments, for example,
MD simulations can be applied to study this.23−25,29 Long-
range atomistic MD simulations were performed to elucidate
structure−function relationships and mechanistic implications
related to the origin of regioselectivity in both enzymes.
■ METHODS
An initial structure for the MD simulations of the wild-type full
complex PrnA was created from the pdb structure of the
enzyme (PDBID: 2AR8).15 The product 7-chlorotryptophan
was separated to create tryptophan and hypochlorous acid; in
addition, the chloride ion bound at the FAD-binding site was
removed and FAD was modiﬁed to create hydroxy-FAD (from
this point forward, FAD will refer to hydroxy-FAD). These
changes were made with the aim to create the active full
complex before the halogenation of Trp-S. Modiﬁcation of the
atomic coordinates was performed using Maestro 9.9.013.30
Structures of the mutant forms K79A and E346Q were
prepared by changing the respective residues in the wild-type
full complex structure using Maestro.30 The initial structure of
PyrH (PDBID: 2WET) for MD simulations was prepared by
superimposing the pdb structure with that of the wild-type full
complex PrnA. The coordinates of hypochlorous acid from this
were then added to 2WET, as they were not present in the
crystal structure.16 In addition to this, the sulfate and chloride
ions from the crystal structure were also removed. The
parameters for FAD and hypochlorous acid were generated
by the PRODRG web server31 for the GROMOS96 43a1
forceﬁeld32 with atomic partial charges for hypochlorous acid
supplemented from QM calculations performed by the
Automated Topology Builder web server.33 The missing
coordinates of the two loop regions in the 2WET structure
were modeled using the Modeller34 plug-in for Chimera
1.10.2.35 The setup for PyrH then followed the same protocol
as the one for PrnA. In total, the PrnA full complex had 94 114
atoms and PyrH 97 090 atoms. The hydrogen atoms missing
from the X-ray crystal structure were added using Gromacs
4.5.5.36 To remove unfavorable steric clashes in the starting
structure, in vacuo energy minimization was performed using
the steepest descent algorithm until the maximum force was
less than 100 kJ mol−1 nm−1, the protein was then placed in a
box with periodic boundary conditions. The energy-minimized
protein structure was then solvated using the single point
charge37 model for water. The total charge of the system was
neutralized by adding the correct number of Na+ or Cl− ions to
Figure 3. View of the aligned crystal structures of PrnA and PyrH
rendered with transparent protein ribbons, the FAD-binding straps are
rendered as solid ribbons to highlight them. FAD, Trp-S,
hypochlorous acid, and the active lysine and glutamate residues are
rendered as tubes with carbon atoms colored according to the protein:
PrnA in bright green and PyrH in light blue.
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make the overall charge of the system zero. Another energy
minimization (using the same conditions as described for in
vacuo energy minimization) was then performed to reduce
close contacts between the solvent molecules or the ions that
may be unfavorably close to the protein structure. The energy-
minimized structure was then subject to position-restrained
MD for 50 ps at 300 K, during that, the protein structure was
restrained and the water was allowed to equilibrate. The
position-restrained dynamics simulations were performed in
NVT ensemble, a constant number of particles, volume, and
temperature with a time step of 2 fs. The productive MD was
then carried out with the output structure from the position-
restrained MD providing the initial structure for 1 μs as in NPT
ensemble at a temperature of 300 K. The MD trajectories were
analyzed over the time period of 100−1000 ns, after
equilibration phase was reached, using tools provided in
Gromacs. Visualization and inspection of the trajectories were
performed with visual molecular dynamics.38 Dynamic cross
correlation analysis (DCCA) was performed using the Bio3D
package39 for Rstudio.40 The DCCA is used to visualize which
residues play a role in correlated motions that occur between
diﬀerent components of the protein structure.41 The level of
correlation between each Cα atom can be quantiﬁed and
visualized on a plot, with correlations ranging from +1 to −1,
indicating a strong positive to a negative correlation. This
allows the identiﬁcation of regions in the protein, showing
correlated motion in the simulation.
■ RESULTS AND DISCUSSION
Conformational Dynamics of Full Complex Wild-Type
PrnA. In total, ﬁve 1 μs MD simulations were performed: the
full complex of wild-type PrnA, apoenzyme PrnA, two single
point mutant forms, K79A and E346Q, of PrnA, as well as the
full complex wild-type PyrH.
The root mean square deviation (RMSD) proﬁle for all Cα
atoms for the 1 μs MD simulation of the wild-type full complex
PrnA is 3.5 Å. The RMSD proﬁles of all ﬁve of the 1 μs
simulations (Figure 4) indicated that the initial equilibration
phase was completed after 100 ns. In addition to the 1 μs
simulation, three additional 200 ns MD simulations of the wild-
type full complex of PrnA were performed. These used the
same initial structure but diﬀerent initial velocities (Supporting
Information (SI) Figure S1). These simulations were created to
evaluate the eﬀect of statistical error on the quality of the
simulations. The RMSDs for each of these trajectories was
consistent with the 1 μs wild-type full complex PrnA simulation
indicating good quality of the simulations. The radius of
gyration of all four 1 μs simulations (SI Figure S2) was 23 Å,
showing that the protein remains relatively compact during the
simulation time scale.
Figure 4. RMSD plot of all ﬁve 1 μs MD simulations: the PrnA full complex, apoenzyme PrnA, PyrH full complex, and the K79A and E346Q mutant
forms of PrnA.
Figure 5. Solvent accessible area graph of the PrnA full complex and PrnA apoenzyme simulations.
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The average RMSD of the full complex wild-type PrnA is 3.5
Å and in the apoenzyme PrnA is 3.6 Å, indicating a slight trend
of increased ﬂexibility of the apoenzyme form possibly due to
the absence of bound ligands. The average RMSD of PyrH was
2.8 Å, reﬂecting its relatively lower ﬂexibility compared with
PrnA. The solvent accessible area (SAS) of the apoenzyme
PrnA is lower than the SAS of the full complex wild-type PrnA
(Figure 5). The radius of gyration also indicates a more
compact structure of the apoenzyme form of PrnA with respect
to the full complex PrnA (SI Figure S2). These observations are
consistent with the diﬀerences in the RMSDs of the full
complex PrnA and apoenzyme PrnA, and are indicative of
conformational changes associated with ligand binding and an
opening of the PrnA structure upon ligand binding. PyrH is
characterized as having overall lower levels of ﬂexibility and a
more compact structure than the full complex PrnA (Figure 4
and SI Figure S2).
The root mean square ﬂuctuation (RMSF) proﬁles of the full
complex PrnA and apoenzyme PrnA are presented in Figure 6.
For the full complex PrnA, the peak centered on residue P93
exhibits a high RMSF, reﬂecting its position at a particularly
ﬂexible portion of the loop that precedes key tryptophan
interacting residues: H101, F103, G104, and N105. These
residues are involved in the binding of Trp-S. It is therefore
possible that the ﬂexibility of this loop is related to the binding
and orientation of Trp-S.
A ﬂexible loop consisting of residues 147−159 has a
maximum RMSF value of 6.7 Å (centered on residue G152)
in the full complex PrnA (Figure 6). The same region has an
RMSF value of 1.8 Å in the apoenzyme form of PrnA. This
loop is located on the exterior of the protein and is solvent
exposed, forming several intraloop hydrogen bonds. The loop
immediately precedes S157, a hydrogen bond stabilizing
residue of Trp-S. The RMSD plot of the loop region 147−
159 (Figure 7) shows that the loop is adopting a stable
orientation after 300 ns. In this conformation, S157 forms a
hydrogen bond with the carboxylate of Trp-S. The dynamics of
the loop diﬀer greatly between the full complex wild-type PrnA
and the apoenzyme PrnA, suggesting that a conformational
change occurs in the loop upon binding of Trp-S. In the
apoenzyme, the S157 side chain forms hydrogen bonds with
the neighboring residues A80, M156, and Y443 instead. These
intraloop protein−protein hydrogen bonds stabilize the 149−
159 loop of the apoenzyme and maintain a more compact
conformation, which is reﬂected in the lower RMSD of the loop
in the apoenzyme (Figure 7).
Conformational changes in enzymes are complex and involve
collective motions between diﬀerent regions of the protein
molecule.42 To analyze the collective correlated motions in the
studied tryptophan halogenase enzymes, we performed DCCA.
In the full complex PrnA, a correlated motion between the
portion of the FAD strap region closest to Trp-S (residues 50−
Figure 6. RMSF plot of the PrnA full complex and PrnA apoenzyme simulations.
Figure 7. Plot showing the relationship between the RMSD of the ﬂexible loop region in both the full complex PrnA and the apoenzyme PrnA
spanning residues 147−170 (left y-axis), and the hydrogen-bonding interaction distance between S157 side chain oxygen and Trp-S (right y-axis).
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54) and the important catalytic residue E346 was found, and
supports the idea of the strap region being an important link
between the two binding sites (Figure 8).
In the DCCA plot of the full complex wild-type PrnA (Figure
8), a region of positive correlations corresponds to two areas of
protein from residues 205 to 255 and 305 to 350 (Figure 9).
The area makes up a large part of the FAD-binding site and
contains many important FAD-binding residues. It also
contains important residues from the tryptophan-binding site,
such as E346 and S347.
The region of residues from 355 to 380 that shows
ﬂuctuation in both the RMSF plot (Figure 6) of the full
complex wild-type PrnA and apoenzyme PrnA correspond to a
long α-helix that intersects the FAD- and tryptophan-binding
sites. It contains the tryptophan hydrogen-bonding residue,
Y351. In the DCCA plot of the full complex wild-type PrnA
(Figure 8), this region of residues, 355−380, shows correlation
with an important tryptophan-binding residue W455. A
relatively large span of residues 396−456 directly precedes
the important tryptophan binding residues (Y443, Y444, W455,
E450, F454, and N459) and shows more ﬂuctuation in the full
complex than the apoenzyme (Figure 6). These residues form
several helices joined by short loops. Interactions between the
helices create a compact and less ﬂexible hydrophobic cluster.
Tryptophan-Binding Site Interactions of Wild-Type
PrnA. The high level of regioselectivity of FAD-dependent
halogenases is thought to depend on the proper orientation of
Trp-S.43 Tryptophan positioning and orientation allows for the
respective carbon atom from the indole ring (C7 in PrnA and
C5 in PyrH) to be favorably oriented for the reaction. To
accomplish stable binding of tryptophan, an extensive network
of hydrogen bonds (Figure 10), electrostatic interactions (SI
Figure S3), and van der Waals interactions (Figure 11) were
found. The measured distances of interactions of Trp-S
observed in the X-ray crystal structure and wild-type full
complex PrnA MD simulation are recorded in Tables 1 and 2.15
K79 and E346, thought to be important for hypochlorous acid
activation, are also involved in a network of hydrogen-bonding
and electrostatic interactions that maintain their orientations in
the active site relative to Trp-S and the chlorinating agent,
hypochlorous acid.19,22
Measurements were made between the donor and acceptor
atoms for hydrogen bonds. Measurements for electrostatic
interactions (highlighted in gray) were measured between the
centers of the charged groups.
Figure 8. DCCA plot of the PrnA full complex simulation. Areas of strongly positive correlation are in red and areas of strongly negative correlation
are in blue.
Figure 9. Two DCCA correlated regions described as spanning
residues 205−255 in red and the region spanning from residues 305 to
350 in blue. The important residues E346 and S347 are displayed
along with FAD and the substrate tryptophan in green carbon tubes.
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Trp-S (Table 1) can act as both hydrogen bond donor and
acceptor with its amino nitrogen, carboxylate oxygen, and
indole ring nitrogen atoms. The backbone nitrogen of G104
participates in a hydrogen bond with Trp-S’s carboxylate. This
interaction does not exist in the crystal structure but is stable
during the MD trajectory. The amino group of tryptophan is
hydrogen bonded to the side chain phenolic oxygen of Y443,
and the backbone carbonyl oxygen of F454. The amino group
of tryptophan can also make electrostatic interactions (Table 1)
with the carboxylate of E450 with an average distance of 4.2 Å.
E450 in turn interacts with the side chain amino group of K57
(distance 5.8 Å), which would help more eﬃcient binding of
Trp-S.
Hypochlorous acid can participate in hydrogen bonds and
interactions with charged residues in the enzyme active site.
The hydrogen atom of hypochlorous acid has a partial positive
charge (0.455e) and forms a strong hydrogen bond with the
side chain of E346 (Table 1). In the initial structure of the PrnA
full complex, K79 is in close proximity to hypochlorous acid
and seems a likely candidate for hydrogen bonding; however,
during the MD simulation, hypochlorous acid moves away from
K79, reﬂected in the average distance of 6.7 Å in the MD
(Table 1). The carboxylate side chain of E346 has two oxygen
atoms, OE1 and OE2, with which it is possible to form
hydrogen bonds (Table 1). The E346 carboxylate forms an
electrostatic interaction with the NE2 nitrogen atom of the
protonated H395 side chain. Hypochlorous acid makes strong
hydrogen-bonding interactions with the carboxylate side chain
of E346. The E346 carboxylate side chain also interacts with the
positively charged doubly protonated H395 (Table 1). In the
crystal structure, the indole nitrogen atom of tryptophan forms
a hydrogen bond with the backbone carbonyl oxygen of E346.
However, in the MD simulation, the backbone carbonyl of
E346 moves away from tryptophan to make other hydrogen-
bonding interactions with T348 and the hydroxyl oxygen of
hydroperoxyﬂavin moiety of FAD.10
F103, W455, and H101 form π−π stacking interactions with
tryptophan (respective average distances of 4.7, 5.1, and 6.3 Å).
Throughout the MD simulation, W455 remains close to Trp-S
participating in a stable π−π stacking interaction with the
substrate (Table 2). E346 and hypochlorous acid are also
located in a close proximity to the side chain of W455;
however, W455 does not become halogenated. K79 is not
found in proximity to W455, indicating that the proximity to
Figure 10. Hydrogen-bonding interactions surrounding Trp-S in
PrnA. The distances between the donors and acceptors are shown in
Table 1.
Figure 11. Hydrophobic contacts surrounding Trp-S in PrnA. The
distances between the centers of mass of the Trp-S indole ring and the
hydrophobic amino acid side chains are shown in Table 2.
Table 1. Hydrogen-Bonding and Electrostatic Interactions for the Tryptophan-Binding Site in the Wild-Type Full Complex
PrnA
residue 1 atom 1 residue 2 atom 2 % of the simulation time <3.5 Å average distance in MD (Å) distance in crystal structure (Å)
H395 NE2 E346 OE2 53 3.5 2.5
E346 OE1 HYP O 91 3.0 3.5
E346 OE2 HYP O 90 3.1 5.2
G104 N Trp-S O 82 3.0 6.0
G104 N Trp-S carboxylate 81 3.1 8.0
Y443 OH Trp-S amino 95 3.1 3.1
F454 O Trp-S amino 69 3.4 2.8
H395 NE2 E346 carboxylate n/a 3.7 4.5
E346 carboxylate HYP H n/a 2.5 4.6
K79 NZ HYP O1 n/a 6.7 3.2
E450 carboxylate Trp-S N n/a 4.2 3.8
K57 NZ E450 CD n/a 5.8 10.3
Table 2. Distances between the Centers of Mass between the
Hydrophobic Side Chains and the Indole Ring of Trp-S
residue name and
number
average distance
(Å)
distance in crystal structure
(Å)
I52 6.2 5.0
H101 6.3 5.4
F103 4.7 5.6
W455 5.1 5.9
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both K79 and E346 is needed for the halogenation reaction to
occur.
A positive correlation between residues 100−130 and
residues 475−505 is found in the DCCA of the full complex
wild-type PrnA (Figure 8). The region of residues 475−505
forms a long α-helix running perpendicular to the H101/F103
region. The correlation is likely to be caused by hydrophobic
interactions between the two regions of the loop portions of
the H101/F103 (SI Figure S4). These two regions are
interwoven and any movement in one will aﬀect the other
region as well.
FAD-Binding Site in PrnA. A structural feature previously
observed in the crystal structure of PyrH is the FAD-binding
strap. This strap region is thought to control the binding of
FAD and also hypothesized to act as a line of communication
between the FAD-binding and tryptophan-binding sites in
PyrH.16 In the crystallographic study of PyrH, the electron
density of the strap region is relatively low, implying that it is a
particularly ﬂexible region of PyrH.16 Through inspection of the
crystal structure of PrnA, we found that a similar strap region
superimposes with that of the PyrH crystal structure and would
also exists in PrnA (Figure 3). The high ﬂexibility of the strap
region shown in SI Figure S5, together with its probable
inﬂuence on both FAD and tryptophan (Figure 3), points
toward the strap region fulﬁlling a similar role to the one
hypothesized to perform in PyrH. In both enzymes, the strap
region consists of a long straight section of residues running
parallel to FAD without secondary structure elements (Figure
3). The region of the strap that is in close contact with FAD
forms several hydrogen bonds (SI Figure S6) and hydrophobic
and cation−π interactions (SI Figure S7) with FAD. These are
evident in the crystal structure as well as the MD simulations of
the PrnA wild-type full complex (SI Tables S1 and S2).20
FAD is a relatively large molecule, and in the crystal
structure, it adopts a linear extended conformation, whereas in
the MD, we see it undergoing a structural transition around 200
ns to adopt a bent conformation (SI Figure S8). We also see
this structural transition of FAD in the MD simulations of PrnA
and PyrH. In the PrnA full complex simulation, the change in
the conformation of FAD happens simultaneously with a
structural transition seen in the FAD strap region (SI Figure
S5). After 200 ns, the strap adopts a conformation that shows
reduced structural ﬂexibility. In comparison, the RMSD of the
strap region in the apoenzyme form of PrnA shows a higher
ﬂexibility as well as larger ﬂuctuations (SI Figure S5). The
increased ﬂexibility of the strap region in the apoenzyme PrnA
MD in contrast to the full complex PrnA MD suggests that the
strap region is involved in the binding of FAD and becomes
more stable in its presence, which can be seen by comparing
hydrogen-bonding interactions of FAD in the X-ray crystal
structure to those from the MD (SI Table S2).
The RMSF proﬁle of the strap region (SI Figure S9) shows
that although the strap region in the apoenzyme form of PrnA
possesses a higher ﬂexibility than the strap region in the full
complex PrnA form, this is mainly due to the high ﬂexibility of
residues 45−49. These residues are located in close proximity
to the ﬂavin moiety of FAD and form stable hydrogen-bonding
interactions with it (SI Table S2). The region of residues from
50 to 53 connects the FAD-binding residues to those of the
tryptophan-binding site. S54 hydrogen bonds E450, which is a
key residue for the binding of the amino group of tryptophan.
The equilibration of the strap region and FAD after 150 ns
causes a conformational change that brings the side chain of
S54 into the proximity of E450 to form a hydrogen bond (SI
Figure S10). This movement brings E450 into the proximity of
the tryptophan amino group, where it forms an electrostatic
interaction (Table 1). This conformational change provides an
atomistic basis for the predicted communication between FAD
and tryptophan-binding sites. The binding of FAD can
inﬂuence the binding of tryptophan by means of the strap
region running through both domains.
The hydrophobic interactions between FAD and the protein
in the MD simulations and X-ray crystal structure are
predominantly with the ﬂavin moiety of FAD (SI Table S1).
The adenine moiety of FAD also has the potential to form a
cation−π interaction with the side chain of R221 (SI Table S1).
Most hydrogen bonds with the adenine moiety of FAD are
formed with the backbone carbonyl oxygen and nitrogen atoms
of the surrounding residues (SI Table S2). A50, S347, T348,
and I350 are the key residues found to form stable hydrogen-
bonding interactions with the ﬂavin ring moiety of FAD. The
backbone carbonyl groups of E346 and P344 interact with the
hydroxyl group of FAD. The interaction between hydroxy-FAD
and E346 could inﬂuence the communication between FAD
and Trp-S.
Possibility of Direct Contact between FAD- and
Tryptophan-Binding Site/Module. The 1 μs MD simu-
lations show that close contact between FAD and tryptophan
Figure 12. Distance between the center of mass of the binding sites of the substrate tryptophan and the ﬂavin ring moiety of FAD in the PrnA full
complex, PrnA apoenzyme, and PyrH full complex MD simulations.
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does not occur at this time scale. The distance between the
FAD-binding site and the substrate-binding site remains
relatively high during MD. The average distance between the
centers of mass of the FAD- and tryptophan-binding sites was
found to be 12.1, 13.5, and 14.2 Å, respectively, for PrnA full
complex, apoenzyme PrnA, and PyrH full complex MD
simulations (Figure 12). The distance between C4A atom of
FAD and the to-be halogenated carbon of tryptophan (C7/C5)
remains high throughout the MD simulations of PrnA and
PyrH (Table 3). The side chains of residues K79 and E346
remain distant from ﬂavin at the 1 μs time scale of the MD
simulations (Table 3). Some hydrogen bonding is found
between the hydroxyl group of ﬂavin and the backbone
carbonyl oxygen of E346. This would not, however, allow for
direct halogenation of the E346 or K79 side chains (SI Table
S1). These observations support the main catalytic mechanism
in which the intermediary halogenating agent is created at the
FAD-binding site and travels through a channel between the
FAD- and tryptophan-binding sites.15,22
Distances were measured between the lysine (K79/K75 of
PrnA and PyrH, respectively)−NZ, glutamate (E346/E354 of
PrnA and PyrH, respectively), CD, and substrate tryptophan
C7/C5 atoms and the proposed reactive atom of FAD-C4A in
the MD simulations.
Conformational Eﬀects of the Mutations of K79 and
E346. Mutational studies show that both K79 and E346 in
PrnA and K75 and E354 in PyrH play a vital role in the reaction
of chlorination of tryptophan. The residues are conserved
across the known FAD-dependent halogenases: PyrH11
(tryptophan 5-halogenase), Thal12 and SttH13 (tryptophan 6-
halogenases) and RebH,14 and PrnA15 (trypthophan 7-
halogenases), indicating their key roles in the catalysis.44 In
PrnA, the mutation K79A leads to a complete loss of activity
and the mutation E346Q shows activity that is reduced by 2
orders of magnitude to a level where it is barely detectable.15
Although possessing no formal charge, hypochlorous acid has a
strong dipole moment (oxygen −0.456 D and hydrogen 0.445
D calculated by the automated force ﬁeld topology builder33)
and interactions with K79 and E346 will have an inﬂuence on
its position and orientation. To test the stabilizing eﬀect of the
two charged residues and to explain the experimental eﬀects of
the mutations, we performed the MD simulations on in silico
mutated forms of PrnA K79A and E346Q. Without the
electrostatic environment created by both K79 and E346,
hypochlorous acid moves away from tryptophan and back along
the channel toward FAD. In this position, hypochlorous acid is
too distant from tryptophan and would likely be unable to
participate in the halogenation reaction (SI Figure S11). In the
MD simulation of K79A mutant, the hypochlorous acid remains
closer to the ﬂavin ring and forms hydrogen bonds with the O4
atom of FAD. In the E346Q mutant form MD simulation, the
hypochlorous acid moves away from the tryptophan-binding
site along the channel toward FAD, where it forms a hydrogen
bond with T263. This residue, although close to K79, is
separated by internal protein structure and not accessible for
interaction with hypochlorous acid. The simulations of the two
mutant forms show increased hypochlorous acid Cl to Trp-C7
distances relative to the wild-type PrnA. This indicates to us
that both residues are of key importance for the positioning of
hypochlorous acid in proximity to tryptophan.
Comparison of PyrH to PrnA. PyrH and PrnA are
structurally similar enzymes that carry out similar reactions but
exhibit diﬀerent kinetics. PyrH is a more eﬃcient enzyme at
chlorinating tryptophan, it achieves 100% conversion to 5-
chlorotryptophan, whereas under the same conditions, PrnA
converts only 59% of tryptophan to 7-chlorotryptophan, with
Table 3. Average Distances between the Proposed Reactive
Atoms in the Tryptophan-Binding Site
average
distance
PrnA full
complex MD
(Å)
average
distance
PyrH full
complex MD
(Å)
ﬂavin C4Asubstrate tryptophan C7/C5 11.6 11.0
ﬂavin C4Xactive lysine NZ 7.0 6.9
ﬂavin C4Xactive glutamate CD 8.3 10.8
Figure 13. Ribbon structure of PrnA (dark green) and PyrH (gold) structurally aligned with one another. Stick representations of the bound ligands
FAD and tryptophan as well as the active glutamate and lysine residues. Hypochlorous acid and the to-be halogenated carbon of tryptophan are
represented as spheres. Light blue carbons represent PrnA and green carbons represent PyrH. Additional element colors are as follows: nitrogen is
dark blue, oxygen is red, and hydrogen is white.
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the remaining tryptophan unreacted.10 The binding mode of
FAD in both enzymes is almost identical, and the FAD
molecules overlay almost perfectly when the two proteins are
aligned (Figures 3 and 13). The diﬀerences in their
regioselectivity and kinetics probably originate in the
tryptophan-binding domain. The way these two enzymes
bind Trp-S in the active site is quite diﬀerent, Trp-S in PyrH
is oriented in an upside-down position relative to its binding
orientation in PrnA. The benzene moieties of the indole rings
for both PrnA and PyrH are nearly superimposable in the
crystal structure (Figure 14). This indicates that the C5 atom in
PyrH is in an almost identical place to that of the C7 atom in
PrnA. During the MD simulation of PyrH, we observe a
rotation of Trp-S to a slightly diﬀerent orientation, and after
equilibration, this orientation remains relatively stable (SI
Figure S12). Despite this movement, the relative orientation of
the C5 atom of the indole ring of tryptophan toward K75 and
E354 remains the same. The position of hypochlorous acid in
the PyrH MD simulation also remains more stable relative to
the PrnA MD, which is indicated by the lower levels of
ﬂuctuation in the RMSD plot of hypochlorous acid in SI Figure
S13.
The higher eﬃciency of PyrH as an enzyme may correlate
with the reduced ﬂexibility of the PyrH tryptophan-binding site.
A more rigid binding site can make PyrH a more eﬃcient
enzyme for halogenating tryptophan.10 The averaged distances
from the MD trajectories between K79/K75-NZ, hypochlorous
acid Cl, and Trp (C7 in PrnA and C5 in PyrH) are shown in SI
Figures S14 and S15. K79/K75-NZ to hypochlorous acid Cl
and tryptophan C7/C5 in PyrH show that hypochlorous acid
makes more stable interactions with relatively lower levels of
ﬂuctuations between the active lysine and glutamate residues.
The stability of these interactions could mean that more
energetically favorable interactions take place in PyrH as
opposed to PrnA. This could be one of the contributing factors
to the experimentally observed greater catalytic turnover of
PyrH compared to PrnA.
The average RMSD of PyrH was 2.8 Å, which is signiﬁcantly
lower than the PrnA full complex and PrnA apoenzyme
simulations and means that PyrH is less ﬂexible than PrnA
(Figure 4). In the RMSF plot comparing the PyrH full complex
and PrnA full complex MD simulations (SI Figure S16), the
region around G37, which immediately precedes the FAD
binding strap that runs from residues 37−50, we see a similar
feature, the FAD strap region, seen in the RMSF plot of PrnA.
However, in PyrH, this region shows lower levels of ﬂexibility.
In PyrH, both the FAD strap region (SI Figure S17) and FAD
show more conformational ﬂuctuations than those in the PrnA
full complex simulation (SI Figure S18). Due to the diﬀerences
in the tryptophan-binding sites between PyrH and PrnA, we
found no analogous interaction between S50 and E452 in PrnA.
Instead, a direct hydrogen-bonding interaction between the side
chain of S50 and the carboxylate moiety of Trp-S is found (SI
Table S3). This suggests that despite the diﬀerences in
tryptophan-binding between PyrH and PrnA, the role of the
strap region remains the same in the two enzymes.
In PrnA, the ﬂexible loop region, which spans residues 147−
159, might be important for tryptophan binding. In the MD
simulation, we identiﬁed a hydrogen bond between the side
chain of S157 and the carboxylate moiety of tryptophan, which
was aﬀected by the dynamics of the 147−159 loop. We propose
that this relationship is important for tryptophan binding
(Figure 7). In PyrH, there is a similarly positioned ﬂexible loop
that had to be modeled due to its lack of coordinates in the
crystal structure.16 This loop of residues from 148 to 165 in
PyrH is similar to the loop 147−159 in PrnA in that G153 acts
as a hinge residue with several internal hydrogen-bonding
interactions forming within the loop during the MD simulation,
such as between T156 and D149, S151 and D149, and R154
and E150. This loop could play a similar role in PyrH as the
equivalent loop 157−159 does in PrnA, acting as a structural
link between the FAD-binding strap and Trp-S. However, the
residue S157 from PrnA has no analogous residue in PyrH;
instead, F164 is found in a similar spatial position and probably
fulﬁlls a similar role in hydrogen-bonding Trp-S. After
equilibration, F164 forms stable hydrogen-bonding interactions
with Trp-S amino and carboxylate moieties (SI Figure S19).
DCCA of the PyrH full complex (SI Figure S20) shows similar
correlations to PrnA (Figure 8, SI Figure S4).
In general, most of the binding interactions between the
protein, Trp-S, and FAD in PrnA are similar to those in PyrH.
For example, tryptophan is bound in a similar way, i.e.,
positioned between hydrophobic side chains, making π−π
stacking interactions with the indole ring (shown in SI Figure
S21, Table 2 and SI Table S4). In PrnA, W455 is replaced by a
similarly positioned F451 in PyrH, although the distance is
greater (average distance 7.0 Å), therefore making the
interaction weaker and less signiﬁcant for tryptophan binding.
F49 in PyrH occupies a similar position to F454 in PrnA, with
an average distance of 5.3 Å to Trp-S (SI Table S4). H101 and
F103 from PrnA are conserved in PyrH as H92 and F94 and
fulﬁll a similar role as hydrophobic residues in proximity to
Trp-S (SI Table S4).
In PyrH, the amino group of Trp-S interacts electrostatically
with the side chain of E452 (distance of 3.9 Å) (SI Table S5
and Figure S22). In the crystal structure of PyrH, a similar
electrostatic interaction supports E452 and appears to be
created by R96; however, the average distance of this
interaction during the MD simulation is much greater and
therefore weaker than the analogous interaction between K57
and E450 observed in the MD simulation of PrnA. In PyrH, the
important catalytic residue E354 interacts with the protonated
H40 with a similar distance to that of H395 to E346 seen in
PrnA (Table 1 and SI Table S5). Hypochlorous acid forms
Figure 14. View of the aligned crystal structures of PrnA and PyrH
rendered with transparent protein ribbons, PrnA with yellow ribbons,
and PyrH with green ribbons. The substrate tryptophan, hypochlorous
acid, and the active lysine and glutamate residues are rendered as tubes
with carbon atoms colored according to the protein: PrnA in bright
green and PyrH in light blue. The to-be halogenated carbon (C7/C5)
of the substrate tryptophan is rendered as a sphere.
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strong interactions with both the active site K75 and E354. Low
average distances indicate that these interactions are stronger
and more stable than in PrnA (SI Figures S14 and S15). This
may be another contributing factor to the increased eﬃciency
of PyrH as an enzyme.
The greatest diﬀerences in tryptophan binding between PyrH
and PrnA observed in our MD simulations were found in the
hydrogen-bonding interactions between the protein and Trp-S.
The diﬀerent orientations of the substrate between PrnA and
PyrH lead to very diﬀerent hydrogen bonding. In PyrH, the
relative upside-down positioning of tryptophan means that the
tryptophan NE1 atom no longer points toward hypochlorous
acid channel, meaning it is more able to make hydrogen bonds
with the surface residues of the tryptophan binding pocket
(Figures 14 and 15). In PyrH, S345 forms a hydrogen bond
with the Trp-S NE1 atom, S50 is the main residue responsible
for the hydrogen bonding of Trp-S carboxylate moiety and
F164 forms hydrogen bonds with both amino and carboxylate
moiety of tryptophan (SI Table S3).
Similarly, in the PrnA MD simulation, FAD undergoes a
structural transition from a linear to a bent form (SI Figure S8).
The transition occurs much more rapidly in PyrH than in PrnA
(SI Figure S18). This is seen in the loss of several hydrogen
bonds in the crystal structure as compared to the MD
simulation (SI Table S6). The binding mode of FAD in
PyrH shows a high level of similarity to that of PrnA, in that it
is mainly bound by backbone hydrogen bonds (SI Figure S23).
Some of the interactions between hydrophobic side chains and
the adenine and ﬂavin moieties are conserved by similar
residues to those in PrnA in both the crystal structure and MD
simulations (SI Table S7 and Figure S24).
Correlations to Experimental Studies. The simulations
of PrnA and PyrH agree with the experimental crystallographic
studies of both enzymes on the structural organization of these
enzymes and the structural basis of their functions. The
simulations are consistent with the crystallographic data for the
majority of the interactions that stabilize the binding of Trp-S
and FAD in their respective binding sites.15,16
Important justiﬁcation concerning the nature of the reaction
mechanism arises from the observation of the crystal structure
of PrnA and especially by the fact that the FAD-binding site
and tryptophan-binding site are separated by 10 Å.15 Although
experimental studies assert that there is a lack of a potential
large conformational transition that brings into close proximity
the two binding sites, they cannot completely exclude such a
possibility. Instead, the MD simulations for 1 μs of the full
complex, apoenzyme form of PrnA, and full complex PyrH
(Figure 12) demonstrate that there is no such kind of
conformational transition that would bring the two binding
sites together and disfavor the reaction mechanism that
involves direct contact between FAD and Trp-S.
The computational results of the PrnA and PyrH simulations
agree with the experimental studies on the key interactions in
the tryptophan-binding site. The experiments show no activity
in PrnA for the K79A mutant and a 2 order of magnitude
reduction of activity for the E346Q mutant, and our
computational studies provide the atomistic details about
these experimental ﬁndings. Furthermore, the present simu-
lations agree with the overall proﬁle of stabilizing interactions in
the FAD-binding site and further explain the role of the strap
region in both enzymes. Furthermore, the present MD studies
complement and agree with previous QM/MM studies on the
reaction mechanism of PrnA.22
■ CONCLUSIONS
Applying MD simulations, atomistic insights into the
structure−function relationships of two halogenasesPrnA
and PyrHwere gained and the origin of their regioselectivity
was found to be related to structural features. The MD study
showed that during the 1 μs time scale, no major conforma-
tional change occurs that can bring the cofactor FAD and the
substrate tryptophan binding sites together. This conﬁrms the
feasibility of the reaction mechanism that involves ﬁrst
formation of hypochlorous acid in the FAD-binding site and
then its transfer to the tryptophan binding site, where the
halogenation reaction takes place. Key residues involved in
positioning the substrate tryptophan in the enzyme active sites
were identiﬁed. Speciﬁc active site orientation of tryptophan is
likely a key factor in the regioselectivity of the two enzymes.
The MD simulations identiﬁed several ﬂexible regions that have
implications for substrate binding. A possible function was
proposed for the strap region. Atomistic details about the
communication that links the tryptophan and FAD binding
sites were provided. The study of the two mutant forms of
PrnA conﬁrmed the experimental mutagenesis results and
provided a better understanding of the structural basis for
reduced activities observed for these mutants. Analysis of PyrH
and PrnA MD simulations showed that although the two
enzymes share very similar structures, they exhibit ﬁne
diﬀerences in interactions in the respective tryptophan-binding
sites. These observations suggest a structural basis for PyrH as a
more eﬃcient halogenating enzyme.
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